Serum interleukin-18 as a biomarker of disease activity and interstitial lung disease in rheumatoid arthritis
Open Access
- 8 December 2025
- journal article
- research article
- Published by Springer Nature in Egyptian Rheumatology and Rehabilitation
- Vol. 52 (1) , 71
Abstract
Background: Rheumatoid arthritis (RA) is a chronic systemic condition, marked by inflammatory alterations of the synovial tissue in joints, cartilage, and bone. Interleukin-18 (IL-18), a member of the IL-1 family, is a significant pro-inflammatory cytokine that could contribute to the development of RA. We aimed to measure the serum IL-18 level in patients with RA and correlate its level with different disease characteristics, disease activity, and the presence of interstitial lung disease. Methods: A case-control study was conducted on 121 subjects: 60 adult RA patients who met the 2010 ACR/EULAR criteria for RA, and 61 age and sex-matched healthy controls. All patients have undergone a comprehensive evaluation, including a history and physical examination, a disease activity score (DAS28), and chest x-ray and high-resolution computed tomography of the chest. Laboratory investigations included C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), rheumatoid factor (RF), anti-citrullinated protein antibodies (ACPA), and serum IL-18 level. Results: The 60 RA patients were 17 males (28.3%) and 43 females (71.7%) with a mean age of 45.13 ± 13.70 years, and disease duration was 8.86 ± 7.91 years. Interstitial lung disease related to RA was found in 8 RA patients (13.3%). The mean serum IL-18 level among RA patients was (652.3 ± 245.2 pg/mL), while in the control group it was (323.1 ± 106.6 pg/mL) with a statistically significant difference ( p < 0.001). Moreover, the mean level of serum IL-18 in RA patients with interstitial lung disease (ILD) was (896.4 ± 162.7 pg/mL), and this was statistically significant when compared to RA patients without ILD ( p = 0.001). There was a significant positive correlation between IL-18 and ESR, CRP, RF, and DAS28 ( p = 0.013, p = 0.010, p < 0.001, and p < 0.001, respectively). Conclusion: Serum IL-18 was significantly higher in RA patients than in controls; furthermore, it was positively correlated with inflammatory markers and disease activity. An increased IL-18 level was associated with the presence of ILD; thus, IL-18 could be a potential biomarker for assessing RA activity and associated ILD.Keywords
This publication has 27 references indexed in Scilit:
- Epidemiology and clinical characteristics of interstitial lung disease in patients with rheumatoid arthritis from the JointMan databaseScientific Reports, 2023
- The etiology of rheumatoid arthritisJournal of Autoimmunity, 2020
- Autoantibodies and B Cells: The ABC of rheumatoid arthritis pathophysiologyImmunological Reviews, 2019
- Interleukin-18 is associated with the presence of interstitial lung disease in rheumatoid arthritis: a cross-sectional studyScandinavian Journal of Rheumatology, 2018
- The role of autoantibodies in the pathophysiology of rheumatoid arthritisSeminars in Immunopathology, 2017
- The nuclear receptor LXR modulates interleukin-18 levels in macrophages through multiple mechanismsScientific Reports, 2016
- Interleukin-18: A Mediator of Inflammation and Angiogenesis in Rheumatoid ArthritisJournal of Interferon & Cytokine Research, 2011
- Incidence and mortality of interstitial lung disease in rheumatoid arthritis: A population‐based studyArthritis & Rheumatism, 2010
- Expression of interleukin-18, IL-18BP, and IL-18R in serum, synovial fluid, and synovial tissue in patients with rheumatoid arthritisClinical and Experimental Medicine, 2009
- Remission and active disease in rheumatoid arthritis: Defining criteria for disease activity statesArthritis & Rheumatism, 2005